Supervised Walking Assistance for Limited Mobility in Older Patients
Trial Summary
What is the purpose of this trial?
The investigator proposes to conduct a randomized trial of supervised ambulation delivered by mobility technician (MT) up to three times daily, including weekends, to hospitalized medical patients. The aims of the study are to compare the short and intermediate-term outcomes of patients randomized to the intervention versus those patients randomized to receive usual care, to identify patients who are most likely to benefit from the intervention and to assess whether the intervention increases or decreases overall costs of an episode of care, including the cost of the MTs, the index hospitalization and the first 30 days post enrollment.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Mobility Technician-Assisted Ambulation for improving mobility in older patients?
Research shows that using Mobility Technicians (MTs) in hospitals helps older patients move more, which can lead to better recovery and shorter hospital stays. In one study, patients who received help from MTs were more likely to go home sooner and spent less time in the hospital, saving costs and improving hospital efficiency.12345
Is supervised walking assistance safe for older patients with limited mobility?
Research on devices similar to supervised walking assistance, like active assist transfer devices and robotic walkers, suggests they are generally safe. These devices have shown positive outcomes in terms of safety and satisfaction, although more rigorous studies are needed to confirm these findings.678910
How is the Mobility Technician-Assisted Ambulation treatment different from other treatments for limited mobility in older patients?
The Mobility Technician-Assisted Ambulation treatment is unique because it involves a supervised walking aid that partially relieves body weight, providing stability and facilitating movement for those with severe mobility issues. Unlike traditional walkers, this treatment includes a motorized, self-propelled mechanism that helps maintain step symmetry and reduces the physical effort required from the patient.1112131415
Research Team
Michael Rothberg, M.D.
Principal Investigator
The Cleveland Clinic
Eligibility Criteria
This trial is for people aged 65 or older who are admitted to a medical service, have completed necessary health checks, and have a certain level of mobility. They must be insured with Traditional Medicare or Medicare Advantage. It's not for those with significant language barriers (except Spanish at Baystate), planned discharges, upcoming surgeries, severe heart conditions, long-term nursing home residents, on comfort care only, admitted over 48 hours ago, or with active infections requiring isolation.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive supervised ambulation up to 3 times daily with a Mobility Technician (MT) until discharge or a maximum of 10 days
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of falls, physical function, and activities of daily living
Extended Follow-up
Assessment of total episode cost and frailty, including non-medication costs for 6 months post-enrollment
Treatment Details
Interventions
- Mobility technician
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Cleveland Clinic
Lead Sponsor
National Institute on Aging (NIA)
Collaborator